Skip to main content

Table 3 Practical recommendations for healthcare providers

From: “It’s only fatness, it doesn’t kill”: a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda

Regular discussion with patients about their own appearance and body weight preferences to inform treatment and weight management plans

Active vigilance and monitor weight gain and potential development of co-morbidities in DTG patients, including regular weighing and recording of weight

Baseline screening patients during ART initiation to identify those with high risks for overweight and diabetes for targeted support

Information about DTG side effects should be provided through leaflet along with verbal explanation by HCWs; regular update of the leaflets with new side effects discovered

Treatment education and counselling should be conducted through group sessions along with one-to-one engagement with patients

Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us